Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Sarah Vasilko

Physician Assistant Johnstown, PA Physician Assistant

NPI 1295055416 CMS profile 11205216

1 Tech Park Dr Ste 2100, Johnstown, PA 15901

Open in the dashboard

General payments

$4,977

238 records reported · program years 2021–2025

Research payments

$1,750

Paid to them · 6 records reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sarah Vasilko of Johnstown, PA is reported in the CMS Open Payments database as having received $4,977 across 238 general payments and $1,750 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 94th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,061 60
2024 General $1,366 63
2023 General $1,093 53
2023 Research $1,350 5
2022 General $1,202 54
2022 Research $400 1
2021 General $255 8

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sarah Vasilko
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Sarah Vasilko were reported at $1,061. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Sarah Vasilko Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $255 $132 $37–$438 $132
2022 $1,202 $155 $48–$522 $149
2023 $1,093 $167 $52–$557 $160
2024 $1,366 $178 $55–$600 $164
2025 $1,061 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $1,203 63 payments
  2. Inari Medical, Inc. $560 21 payments
  3. Janssen Pharmaceuticals, Inc $433 29 payments
  4. Boston Scientific Corporation $386 15 payments
  5. E.R. Squibb & Sons, L.L.C. $368 19 payments
  6. Novartis Pharmaceuticals Corporation $298 15 payments
  7. Abiomed $198 6 payments
  8. Merck Sharp & Dohme Corporation $151 8 payments
  9. Boehringer Ingelheim Pharmaceuticals, Inc. $126 7 payments
  10. Novo Nordisk Inc $114 1 payment
  11. Other $1,141 54 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $4,977 238 payments
Products named General payments · program years 2021–2025
  1. LifeVest $1,203 63 payments
  2. CT THROMBECTOMY SYSTEM KIT $623 24 payments
  3. FLOWTRIEVER CATHETER, S $623 24 payments
  4. XARELTO $433 29 payments
  5. CAMZYOS $216 11 payments
  6. LEQVIO $213 10 payments
  7. WATCHMAN FLX $206 8 payments
  8. VERQUVO $192 10 payments
  9. WATCHMAN Access System $180 7 payments
  10. ELIQUIS $133 7 payments
  11. Other $1,656 77 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2021–2025
  1. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $1,750 6 payments

Prescribing to Medicare patients

Part D · data year 2024 · 17 drugs

Part D claims

592

Median for Physician Assistant: 241

Drug cost

$109,838

Median for Physician Assistant: $4,110

Branded share of claims

45.9%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 67 $57,498
Brilinta Ticagrelor Brand 40 $23,883
Entresto Sacubitril/Valsartan Brand 18 $11,519
Farxiga Dapagliflozin Propanediol Brand 14 $11,333
Metoprolol Succinate Generic 43 $1,142
Atorvastatin Calcium Generic 74 $949
Isosorbide Mononitrate Er Isosorbide Mononitrate Brand 46 $772
Diltiazem 24hr Er (Cd) Diltiazem Hcl Brand 27 $740
Clopidogrel Clopidogrel Bisulfate Brand 60 $426
Metoprolol Tartrate Generic 52 $325

The 10 drugs with the highest cost, of 17 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 13 billing codes

Paid by Medicare

$19,851

Medicare's payments for the services billed

Medicare patients

180

Average age 76

Services billed

324

80 women, 100 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 64%
Arthritis 59%
Heart failure 49%
Chronic kidney disease 48%
Diabetes 47%
Atrial fibrillation 43%
Depression 31%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 11 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Repatha
  • Amgen Inc. $67
$67 — —
LEQVIO
  • Novartis Pharmaceuticals Corporation $62
$62 — —
ELIQUIS
  • E.R. Squibb & Sons, L.L.C. $59
$59 67 —
Kerendia
  • Bayer HealthCare Pharmaceuticals Inc. $47
$47 — —
VERQUVO
  • Merck Sharp & Dohme Corporation $41
$41 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 11 in the dashboard with a free account

Records

244 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record